Johnson & Johnson Becomes Oversold Wednesday, August 17, 11:36 AM ET, by Market News Video Staff The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, ...
The Guggenheim EW Euro-Pacific LDRs ETF (EEN) - formerly the Claymore/BNY Mellon EW Euro-Pac LDRs ETF - appears to be trading at a discount to NAV. According to the last reported NAV value (EEN.NV), the NAV per share is showing $19.2099 as of the time this article is being published. The closing price on EEN from yesterday was $19.25, placing the ETF at a 3.7% discount to NAV.
The top holding of this ETF is Crucell N.V. (CRXL). On October 6, Johnson & Johnson (NYSE:JNJ) and Crucell N.V. announced an agreement whereby Johnson & Johnson would acquire all outstanding equity of Crucell that it does not already own for approximately euro 1.75 billion in a recommended cash tender offer.
The ETF also holds Elan Corp (ELN), Melco Crown Entertainment (NASDAQ:MPEL), amongst other ADRs.
This Article's Word Cloud:ADRsAccordingCRXLClaymoreCorpCrownCrucellElanEuroJohnsonLDRsMPELMelcoOctoberPacificacquireagreementalreadyalsoamongstappearsapproximatelyarticlebeingclosingdiscountdoesequityformerlyfromholdingholdsofferotheroutstandingplacingpricepublishedreportedshareshowingtenderthatthistimetradingvaluewherebywouldyesterday
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.